Weekly Updates
Insights from our weekly G2G Bio Bulletin
G2G Bio Bulletin – April 7, 2026
Federal Legislative Updates Ohio Legislative Updates G2G Blog Back to All Posts Funding & Other Opportunities New ARPA-H Program: Systematic Targeting Of MicroPlastics (STOMP). Highlights: Across two phases STOMP aims…
G2G Bio Bulletin – March 31, 2026
Federal Legislative Updates Ohio Legislative Updates G2G Blog Back to All Posts April 3, 2026 Update The SBIR/STTR Reauthorization Bill (S. 3971) was presented to President Trump yesterday. This means: If he…
G2G Bio Bulletin – March 23, 2026
Committee leaders from both parties have taken actions and floated proposals to address healthcare costs and improve access to medicines.
G2G Bioscience Bulletin – March 16, 2026
G2G with Women’s Health Advocates (WHA) the Endo & Adeno Coalition, Krampz Wellness and partners organized an Endometriosis & Adenomyosis Capitol Hill Day on March 10 and an accompanying Congressional Briefing on March 9 to advocate for better research and care for patients.
G2G Bio Bulletin – March 8, 2026
On Tuesday, the Senate Committee on Commerce, Science & Transportation’s Science Subcommittee convened a hearing on applications of AI. Witnesses were affiliated with RadAI, Siemens, Agility Robotics and the Brookings Institution.
G2G Bio Bulletin – March 1, 2026
G2G’s DC team was on Capitol Hill this week, alongside dozens of advocates and stakeholders from across the country.
G2G Bio Bulletin – February 21, 2026
The Congressionally Directed Medical Research Programs (CDMRP) has released pre-announcements for the FY 26 Spinal Cord Injury, ALS, Arthritis, Ovarian Cancer, Pancreatic Cancer and Tick-Borne Disease Research Programs.
G2G Bio Bulletin – February 14, 2026
The Congressionally Directed Medical Research Programs (CDMRP) has released pre-announcements for FY26 Breast Cancer Research Program (BCRP) and Lupus Research Program (LRP)
G2G Bioscience Bulletin – February 7, 2026
Federal Legislative Updates Ohio Legislative Updates G2G Blog Back to All Posts Funding Opportunity DARPA BTO has announced a new program, Protean. Key details are as follows: Aims to advance the…
G2G Bioscience Bulletin – January 31, 2026
ARPA-H announced a new program BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI).
G2G Bioscience Bulletin – January 23, 2026
G2G Founder & CEO Liz Powell was in Birmingham, AL in her capacity as a leader of Women’s Health Advocates, to convene an event that brought together elected officials, medical professionals, doulas, community advocates and educators to examine the policies and systems shaping maternal health outcomes.
G2G Bioscience Bulletin – January 17, 2026
G2G Founder & CEO Liz Powell was at JP Morgan where she engaged with innovators, leaders and investors from across the healthcare and the life sciences sectors. Notably, Liz with other women’s health leaders presented the release of the Follow the Exits: Why Women’s Health Is a Smart Bet in Healthcare report.